These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 8794503)

  • 1. Relapse in schizophrenia: is there a relationship to substance abuse?
    Gupta S; Hendricks S; Kenkel AM; Bhatia SC; Haffke EA
    Schizophr Res; 1996 May; 20(1-2):153-6. PubMed ID: 8794503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance use: a powerful predictor of relapse in schizophrenia.
    Swofford CD; Kasckow JW; Scheller-Gilkey G; Inderbitzin LB
    Schizophr Res; 1996 May; 20(1-2):145-151. PubMed ID: 8794502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in substance abuse patterns: multiple drug abuse alone versus schizophrenia with multiple drug abuse.
    Lammertink M; Löhrer F; Kaiser R; Hambrecht M; Pukrop R
    Acta Psychiatr Scand; 2001 Nov; 104(5):361-6. PubMed ID: 11722317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Schizophrenia and substance dependence].
    Uchtenhagen A
    Schweiz Arch Neurol Psychiatr (1985); 1995; 146(5):215-23. PubMed ID: 8658102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychopharmacology: insight and comorbid substance misuse and medication compliance among patients with schizophrenia.
    Kamali M; Kelly L; Gervin M; Browne S; Larkin C; O'Callaghan E
    Psychiatr Serv; 2001 Feb; 52(2):161-3, 166. PubMed ID: 11157110
    [No Abstract]   [Full Text] [Related]  

  • 6. Comorbid substance abuse and recovery from acute psychiatric relapse.
    Sanguineti VR; Samuel SE
    Hosp Community Psychiatry; 1993 Nov; 44(11):1073-6. PubMed ID: 8288176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug abuse in schizophrenia: comparison of patients who began drug abuse before their first admission with those who began abusing drugs after their first admission.
    Silver H; Abboud E
    Schizophr Res; 1994 Aug; 13(1):57-63. PubMed ID: 7947416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].
    Verdoux H; Mury M; Besançon G; Bourgeois M
    Encephale; 1996; 22(2):95-101. PubMed ID: 8706627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication compliance and substance abuse among schizophrenic patients.
    Pristach CA; Smith CM
    Hosp Community Psychiatry; 1990 Dec; 41(12):1345-8. PubMed ID: 1980483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schizophrenia and substance abuse.
    Smith J; Hucker S
    Br J Psychiatry; 1994 Jul; 165(1):13-21. PubMed ID: 7953023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [History of treatment of schizophrenic forensic patients prior to admission: a comparison with schizophrenic general psychiatric patients].
    Piontek K; Kutscher SU; König A; Leygraf N
    Nervenarzt; 2013 Jan; 84(1):55-64. PubMed ID: 22215217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Attributable risk of co-morbid substance use disorder in poor observance to pharmacological treatment and the occurrence of relapse in schizophrenia].
    Ameller A; Gorwood P
    Encephale; 2015 Apr; 41(2):174-83. PubMed ID: 25838239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Noordsy DL; Xie H; Drake RE
    Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self reports of the interaction between substance abuse and schizophrenia.
    Baigent M; Holme G; Hafner RJ
    Aust N Z J Psychiatry; 1995 Mar; 29(1):69-74. PubMed ID: 7625979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapse.
    Hunt GE; Bergen J; Bashir M
    Schizophr Res; 2002 Apr; 54(3):253-64. PubMed ID: 11950550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance abuse and cognitive functioning in schizophrenia.
    Addington J; Addington D
    J Psychiatry Neurosci; 1997 Mar; 22(2):99-104. PubMed ID: 9074303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication noncompliance and substance abuse among patients with schizophrenia.
    Owen RR; Fischer EP; Booth BM; Cuffel BJ
    Psychiatr Serv; 1996 Aug; 47(8):853-8. PubMed ID: 8837158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia.
    Potvin S; Stip E; Lipp O; Roy MA; Demers MF; Bouchard RH; Gendron A
    Am J Drug Alcohol Abuse; 2008; 34(1):75-82. PubMed ID: 18161645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug abuse and/or dependence and better neuropsychological performance in patients with schizophrenia.
    Joyal CC; Hallé P; Lapierre D; Hodgins S
    Schizophr Res; 2003 Oct; 63(3):297-9. PubMed ID: 12957709
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.